PT826370E - Preparacao farmaceutica que contem 2-fenil-1, 2-benzoisoelenazol-3(2h)-ona, para o tratamento da doenca de alzheimer - Google Patents

Preparacao farmaceutica que contem 2-fenil-1, 2-benzoisoelenazol-3(2h)-ona, para o tratamento da doenca de alzheimer

Info

Publication number
PT826370E
PT826370E PT97104503T PT97104503T PT826370E PT 826370 E PT826370 E PT 826370E PT 97104503 T PT97104503 T PT 97104503T PT 97104503 T PT97104503 T PT 97104503T PT 826370 E PT826370 E PT 826370E
Authority
PT
Portugal
Prior art keywords
alzheimer
phenyl
treatment
benzoisoelenazol
disease
Prior art date
Application number
PT97104503T
Other languages
English (en)
Inventor
Kazuhiro Abeyama
Ikuro Maruyama
Hiroyuko Masayasu
Original Assignee
Nattermann A & Cie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nattermann A & Cie filed Critical Nattermann A & Cie
Publication of PT826370E publication Critical patent/PT826370E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
PT97104503T 1996-08-27 1997-03-17 Preparacao farmaceutica que contem 2-fenil-1, 2-benzoisoelenazol-3(2h)-ona, para o tratamento da doenca de alzheimer PT826370E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP22551296 1996-08-27

Publications (1)

Publication Number Publication Date
PT826370E true PT826370E (pt) 2002-10-31

Family

ID=16830487

Family Applications (1)

Application Number Title Priority Date Filing Date
PT97104503T PT826370E (pt) 1996-08-27 1997-03-17 Preparacao farmaceutica que contem 2-fenil-1, 2-benzoisoelenazol-3(2h)-ona, para o tratamento da doenca de alzheimer

Country Status (29)

Country Link
US (1) US5948800A (pt)
EP (1) EP0826370B1 (pt)
KR (1) KR20000035859A (pt)
CN (1) CN1112922C (pt)
AT (1) ATE219361T1 (pt)
AU (2) AU3866997A (pt)
BR (1) BR9711259A (pt)
CA (1) CA2213794C (pt)
CZ (1) CZ295364B6 (pt)
DE (2) DE59707550D1 (pt)
DK (1) DK0826370T3 (pt)
EE (1) EE03953B1 (pt)
ES (1) ES2177849T3 (pt)
FI (1) FI119622B (pt)
HK (1) HK1020317A1 (pt)
HU (1) HU225264B1 (pt)
IL (1) IL127113A (pt)
LT (1) LT4602B (pt)
LV (1) LV12251B (pt)
NO (1) NO312812B1 (pt)
NZ (1) NZ332292A (pt)
PL (1) PL188481B1 (pt)
PT (1) PT826370E (pt)
SI (1) SI9720060B (pt)
TR (1) TR199700858A2 (pt)
TW (1) TW501925B (pt)
UA (1) UA59367C2 (pt)
WO (2) WO1998008511A1 (pt)
ZA (1) ZA977644B (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0729756T3 (da) * 1993-10-27 2000-06-05 Daiichi Seiyaku Co Granulært farmaceutisk præparat
JP2000016935A (ja) * 1998-07-01 2000-01-18 Dai Ichi Seiyaku Co Ltd シクロオキシゲナーゼ阻害剤
CA2368484A1 (en) 1999-03-31 2000-10-05 Daiichi Pharmaceutical Co., Ltd. Substrates for thioredoxin reductase
WO2003010154A1 (en) * 2001-07-26 2003-02-06 Samsung Electronics Co. Ltd. Seleno compounds containing nitrone moiety, their preparation and their therapeutic uses
WO2003010143A1 (en) 2001-07-26 2003-02-06 Samsung Electronics Co., Ltd. Dialkylhydroxybenzoic acid derivatives containing metal chelating groups and their therapeutic uses
WO2003010153A1 (en) 2001-07-26 2003-02-06 Samsung Electronics Co. Ltd. N-alkyl-n-phenylhydroxylamine compounds containing metal chelating groups, their preparation and their therapeutic uses
GB201102248D0 (en) 2011-02-09 2011-03-23 Isis Innovation Treatment of bipolar disorder
CN103965188A (zh) * 2013-01-29 2014-08-06 中山大学 含硒多奈哌齐类似物
EP2950102A1 (en) 2014-05-30 2015-12-02 Biocross, S.L. Method for the diagnosis of alzheimer s disease and mild cognitive impairment
US10058542B1 (en) 2014-09-12 2018-08-28 Thioredoxin Systems Ab Composition comprising selenazol or thiazolone derivatives and silver and method of treatment therewith
EP3067699A1 (en) 2015-03-11 2016-09-14 Neuron Bio, S.A. Method for diagnosing alzheimer's disease
PL237739B1 (pl) 2018-06-06 2021-05-17 Univ Gdanski Genisteina do zastosowania do leczenia choroby Alzheimera
CN113116888B (zh) * 2021-04-19 2022-08-26 上海兴糖生物技术有限公司 依布硒啉的用途

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3616923A1 (de) * 1986-05-20 1987-11-26 Nattermann A & Cie Neue pharmazeutische verwendung von 2-phenyl-1,2-benzisoselenazol-3(2h)-on
DE3638124C2 (de) * 1986-11-08 1996-09-05 Nattermann A & Cie Neue pharmazeutische Verwendung von Ebselen
JPH01131113A (ja) * 1987-08-27 1989-05-24 Dai Ichi Seiyaku Co Ltd 脳障害治療剤
JPH0238591A (ja) 1988-07-27 1990-02-07 Fujikura Ltd 高純度銅の製造方法
US5385726A (en) * 1990-08-06 1995-01-31 Rhone-Poulenc Rorer Gmbh Use of 2-phenyl-1,2-benzisoselenazol-3-(2H)-one
DE4024885C2 (de) * 1990-08-06 2002-07-18 Nattermann A & Cie Verwendung von 2-Phenyl-1,2-benzisoselenazol-3(2H)-on
FR2669633B1 (fr) * 1990-11-23 1993-01-22 Adir Nouveaux derives de la benzoselenazolinone, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
JPH07233056A (ja) * 1993-09-03 1995-09-05 Dai Ichi Seiyaku Co Ltd リポキシゲナーゼ阻害剤

Also Published As

Publication number Publication date
HK1020317A1 (en) 2000-04-14
UA59367C2 (uk) 2003-09-15
CN1112922C (zh) 2003-07-02
HUP9903213A3 (en) 2000-12-28
AU3529897A (en) 1998-03-05
FI982689A0 (fi) 1998-12-11
NO973912L (no) 1998-03-02
SI9720060B (en) 2001-12-31
ZA977644B (en) 1999-02-26
TW501925B (en) 2002-09-11
LV12251B (lv) 1999-08-20
HUP9903213A1 (en) 2000-07-28
KR20000035859A (ko) 2000-06-26
FI982689A (fi) 1998-12-11
EE9900007A (et) 1999-06-15
ATE219361T1 (de) 2002-07-15
PL321796A1 (en) 1998-03-02
BR9711259A (pt) 1999-08-17
US5948800A (en) 1999-09-07
HU225264B1 (en) 2006-08-28
LT4602B (lt) 2000-01-25
CZ295364B6 (cs) 2005-07-13
TR199700858A2 (xx) 1998-03-21
PL188481B1 (pl) 2005-02-28
NO973912D0 (no) 1997-08-26
DE59707550D1 (de) 2002-07-25
SI9720060A (sl) 1999-06-30
FI119622B (fi) 2009-01-30
AU3866997A (en) 1998-03-19
IL127113A0 (en) 1999-09-22
CZ31799A3 (cs) 1999-11-17
WO1998008831A1 (fr) 1998-03-05
IL127113A (en) 2003-07-06
AU725534B2 (en) 2000-10-12
EP0826370A1 (de) 1998-03-04
CA2213794A1 (en) 1998-02-27
EP0826370B1 (de) 2002-06-19
CA2213794C (en) 2006-10-03
NZ332292A (en) 2001-07-27
CN1223580A (zh) 1999-07-21
WO1998008511A1 (de) 1998-03-05
ES2177849T3 (es) 2002-12-16
LT99016A (en) 1999-10-25
LV12251A (lv) 1999-04-20
DE19733690A1 (de) 1998-03-26
DK0826370T3 (da) 2002-10-07
NO312812B1 (no) 2002-07-08
EE03953B1 (et) 2003-02-17

Similar Documents

Publication Publication Date Title
LV12438A (en) Metode of preventing and delyaing the onset of alzheimer's disease and composition thereof
DK549189D0 (da) Galanthamin-analoge samt anvendelse af disse til fremstilling af laegemidler til behandling af alzheimer's syge
EP0735870A4 (en) USE OF PHOSPHOLIPASE-A2 INHIBITORS FOR TREATING ALZHEIMER'S DISEASE
PT826370E (pt) Preparacao farmaceutica que contem 2-fenil-1, 2-benzoisoelenazol-3(2h)-ona, para o tratamento da doenca de alzheimer
DE68923819D1 (de) Verwendung von gamma-Hydroxy-Buttersäuresalzen zur Herstellung von pharmazeutischen Zusammensetzungen zur Verwendung bei der Behandlung von Alkoholismus und die hergestellten Zusammensetzungen.
FI950909A (fi) Rasvahappojohdannaisia
NZ504419A (en) The use of carvedilol for treating amyloid diseases such as Alzheimer's
TR200000455T2 (tr) Alzheimer hastalığının tedavisinde fankinonun kullanılması.
MX9704034A (es) Derivados y composiciones de 1,1-dioxido de 2-arilcarboniloximetil-1,2,5-tiadiazolidin-3-ona substituido y metodo de uso.
AU3992897A (en) Use of sulbutiamine to obtain pharmaceutical compositions useful in the treatment of certain psychomotor and psycho-intellectual disorders
SE8802323D0 (sv) 8alfa-acylaminoergoline, its preparation and pharmaceutical compositions containing it
ZA961897B (en) 6,7-substituted-2-aminotetralines and use thereof
RS49595B (sr) Primena 2-fenil-1,2- benzizoselenazol-3(2h)-ona za izradu farmaceutskog preparata za lečenje alchajmerove bolesti
Greer Effects of NaCl on tobacco callus cultures